title: Highlights from the 21st CROI.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Cooney
authors.forename: Peter
authors.initials: P
authors.lastname: Hayward
mesh_terms: D000818:Animals; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D003271:Contraceptive Agents, Female / Q000008:administration & dosage*; D003692:Delayed-Action Preparations; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000517:prevention & control* / Q000635:transmission*; D006526:Hepatitis C / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D055118:Medication Adherence; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D009640:Norethindrone / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D019380:Anti-HIV Agents; D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate; C024319:norethindrone enanthate; D009640:Norethindrone